The use of oral fosfomycin-trometamol in patients with catheter-associated urinary tract infections (CAUTI): new indications for an old antibiotic?

References

• Jiménez-Alcaide E, Medina-Polo J, García-González L, Arrébola-Pajares A, Guerrero-Ramos F, Pérez-Cadavid S, et al. Healthcare-associated urinary tract infections in patients with a urinary catheter: Risk factors, microbiological characteristics and patterns of antibiotic resistance. Arch Esp Urol. 2015;68(6):541–50.
   PubMed Web of Science ®Google Scholar
• Bouza E, San Juan R, Muñoz P, Voss A, Kluytmans J; Co-operative Group of the European Study Group on Nosocomial Infections. A European perspective on nosocomial urinary tract infections II. Report on incidence, clinical characteristics and outcome (ESGNI-004 study). European Study Group on Nosocomial Infection. Clin Microbiol Infect. 2001;7(10):532–42.
   PubMed Web of Science ®Google Scholar
• Chant C, Smith DM, Marshall JC, Friedrich JO. Relationship of catheter-associated urinary tract infection to mortality and length of stay in critically ill patients: a systematic review and meta-analysis. Ann Intern Med. 2013;159:401–10.
   PubMedGoogle Scholar
• Kazi MM, Harshe A, Sale H, Mane D, Yande M, Chabukswar S. Catheter-associated urinary tract infections and antibiotic sensitivity pattern from confirmed cases of CAUTI in a tertiary care hospital: a prospective study. J Clin Microbiol. 2015;4:193:doi:10.4172/2327-5073.1000193.
   Google Scholar
• Cai T, Gallelli L, Meacci F, Brugnolli A, Prosperi L, Roberta S, et al. The efficacy of umbelliferone, arbutin, and N-acetylcysteine to prevent microbial colonization and biofilm development on urinary catheter surface: results from a preliminary study. J Pathog. 2016;2016:1590952.
   PubMedGoogle Scholar
• Vergidis P, Patel R. Novel approaches to the diagnosis, prevention, and treatment of medical device-associated infections. Infect Dis Clin North Am. 2012;26(1):173–86.
   PubMed Web of Science ®Google Scholar
• Tenke P, Köves B, Nagy K, Hultgren SJ, Mendling W, Wullt B, et al. Update on biofilm infections in the urinary tract. World J Urol. 2012;30(1):51–7.
   PubMed Web of Science ®Google Scholar
• Sabir N, Ikram A, Zaman G, Satti L, Gardezi A, Ahmed A, et al. Bacterial biofilm-based catheter-associated urinary tract infections: Causative pathogens and antibiotic resistance. Am J Infect Control. 2017;45(10):1101–5.
   PubMed Web of Science ®Google Scholar
• Abdullah NMA, Elasayed SB, Mustafa MMY, El-gohary GM. Biofilm forming bacteria isolated from urinary tract infection, relation to catheterization and susceptibility to antibiotics. Int J Biotechnol Mol Biol Res. 2011;2:172–8.
   Google Scholar
• Falagas ME, Kastoris AC, Kapaskelis AM, Karageorgopoulos DE. Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis. 2010;10(1):43–50.
   PubMed Web of Science ®Google Scholar
• Gian J, Cunha BA. Raoultella planticola chronic bacterial prostatitis with prostatic calcifications: successful treatment with prolonged fosfomycin therapy. Int J Antimicrob Agents. 2016;47(5):414.
   PubMed Web of Science ®Google Scholar
• Los-Arcos I, Pigrau C, Rodríguez-Pardo D, Fernández-Hidalgo N, Andreu A, Larrosa N, et al. Long-term fosfomycin-tromethamine oral therapy for difficult-to-treat chronic bacterial prostatitis. Antimicrob Agents Chemother. 2015;60(3):1854–8.
   PubMed Web of Science ®Google Scholar
• Grayson ML, Macesic N, Trevillyan J, Ellis AG, Zeglinski PT, Hewitt NH, et al. Fosfomycin for treatment of prostatitis: new tricks for old dogs. Clin Infect Dis. 2015;61:1141–3.
   PubMed Web of Science ®Google Scholar
• Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–96.
   PubMed Web of Science ®Google Scholar
• European Association of Urology Guidelines on Urological Infections. 2017. Available from http://uroweb.org/wp-content/uploads/19-Urological-infections_LR2.pdf
   Google Scholar
• Hooton TM, Scholes D, Gupta K, Stapleton AE, Roberts PL, Stamm WE. Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial. JAMA 2005;293:949–55.
   PubMed Web of Science ®Google Scholar
• European Committee on Antimicrobial Susceptibility TestingBreakpoint tables for interpretation of MICs and zone diametersVersion 8.1, valid from 2018‐05‐15 - Available from http://www.eucast.org/clinical_breakpoints/
   Google Scholar
• Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, et al.; Infectious Diseases Society of America. Diagnosis, prevention and treatment of catheter-associated urinary tract infection in adults: 2009 international clinical practice guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:625–63.
   PubMed Web of Science ®Google Scholar
• Raz R, Schiller D, Nicolle LE. Chronic indwelling catheter replacement before antimicrobial therapy for symptomatic urinary tract infection. J Urol. 2000;164(4):1254–8.
   PubMed Web of Science ®Google Scholar
• Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, et al.; Infectious Diseases Society of America. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:503–35.
   PubMed Web of Science ®Google Scholar
• Subramanian P, Shanmugam N, Sivaraman U, Kumar S, Selvaraj S. Antiobiotic resistance pattern of biofilm-forming uropathogens isolated from catheterised patients in Pondicherry, India. Australas Med J. 2012;5(7):344–8.
   PubMedGoogle Scholar